Shining a Light on BP-3 Exposure: Sunscreen Chemical Measured in U.S. Population by Tibbetts, John
G
r
a
c
a
 
V
i
c
t
o
r
i
a
/
S
h
u
t
t
e
r
s
t
o
c
k
Is Arsenic “Lactation Intolerant”?
Study Indicates Low Excretion in Breast Milk
Arsenic is known to readily cross the placenta, but few data exist
on postnatal exposure to arsenic in breast milk. Results of a study
conducted in Bangladesh now suggest that infants who are exclu-
sively breastfed are protected against arsenic, despite high maternal
exposures [EHP 116:963–969; Fängström et al.]. 
Numerous studies have linked arsenic exposure in adults to var-
ious diseases, including cancer, cardiovascular disease, and diabetes
mellitus. Exposure in school-age children has been associated with
neurodevelopmental disorders. During fetal development, the
brain is particularly vulnerable to arsenic exposure, as it readily
crosses the placenta, possibly altering fetal programming and lead-
ing to a higher risk of susceptibility to disease later in life. 
The subjects in the current study included 98 mothers and
their 3-month-old infants who participated in the Maternal and
Infant Nutrition Interventions of Matlab in Bangladesh, one of the
most severely affected countries in terms of high prevalence of
extremely elevated levels of arsenic in drinking water supplies. The
investigators evaluated nutritional status and arsenic exposure as
reflected by arsenic metabolites in infant urine and maternal blood,
urine, and saliva samples. They also analyzed breast milk samples at
2 months postpartum for arsenic. Questionnaires completed by the
mothers provided data on infant feeding practices.
The median sum of arsenic metabolites in infant urine was
1.2 µg/L, with significantly lower concentrations in infants who
were exclusively breastfed compared with those who received some
solid food. Arsenic concentrations in breast milk were low (median
1.0 µg/kg) and mostly in the form of trivalent inorganic arsenic. The
researchers observed a significant association between arsenic in infant
urine and breast milk, but noted that some mothers with low breast
milk arsenic had infants with high urine concentrations, possibly
because the infants had been given water to drink. Median maternal
blood and urine concentrations were high (5.7 and 67 µg/L,
respectively), whereas median maternal saliva concentrations were
low (1.3 µg/L). Among infants who were exclusively breastfed, urine
levels did not exceed 19 µg/L inorganic arsenic and its metabolites,
whereas infants who received infant formula prepared with local
drinking water in addition to some breast milk had urine levels up
to 1,100 µg/L.
The authors demonstrate for the first time that arsenic in
human breast milk is mostly the inorganic arsenite form. Although
there was a significant relationship between arsenic concentrations
in milk and in maternal blood, arsenic concentrations in breast
milk were relatively low despite the mothers’ high exposures. The
findings suggest that breastfeeding exclusively can protect infants
from arsenic exposure during this critical development period, but
the authors note that researchers have yet to determine the extent
to which breastfeeding decreases the health risks associated with
prenatal arsenic exposure. –Tanya Tillett
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Shining a Light on BP-3 Exposure
Sunscreen Chemical Measured in U.S. Population
Sunscreens provide important protection against sunburn and squa-
mous cell cancer, particularly for individuals who work outdoors or
in situations where sun exposure is unavoidable. The widespread use
of the common sunscreen agent benzophenone-3 (BP-3) and its
detection in the environment suggest the need for more information
about the extent of human exposure. Results of a new study now
provide the first nationally representative data on BP-3 exposure
among the U.S. population [EHP 116:893–897; Calafat et al.]. 
BP-3 is used in personal care products to absorb and dissipate
ultraviolet (UV) radiation. It is also used as a UV stabilizer in plastic
surface coatings to prevent polymer or food
photodegradation and has been approved by
the Food and Drug Administration as an
indirect food additive. Although BP-3 expo-
sure has not been linked to adverse health
effects in humans, results of animal studies
by the National Toxicology Program have
shown effects in liver, kidney, and reproduc-
tive organs, and studies by other groups
have shown endocrine-disrupting effects. 
Using data from the National Health and
Nutrition Examination Survey (NHANES)
2003–2004 conducted by the Centers for
Disease Control and Prevention, the current
research team analyzed 2,517 urine samples
from three major racial/ethnic groups: non-
Hispanic black, non-Hispanic white, and
Mexican American. NHANES includes
household interviews, medical histories,
standardized physical examinations, and a
collection of biologic specimens that can be used to assess exposure to
environmental chemicals, as in the current study. 
The scientists detected BP-3 in 96.8% of the urine samples, with
a mean concentration of 22.9 µg/L and a concentration of 1,040 µg/L
in the 95th percentile. The high level of detection likely resulted from
routine use of personal care products such as sunscreen, moisturizers,
lipstick, and hairspray. 
Results of the current study suggest that females and non-
Hispanic whites were the most highly exposed of all the demographic
groups studied. Mean concentrations of BP-3 were significantly
higher for females than for males, regardless of age, probably because
women and girls use more sunscreen and other personal care prod-
ucts than men and boys do. At the 95th percentile of exposure, adult
females had BP-3 concentrations 3.5 times greater than those of
adult males. 
Mean concentrations also differed sig-
nificantly among the different racial/ethnic
groups. Non-Hispanic whites were 6.8 times
more likely and Mexican Americans were
4 times more likely to have BP-3 concentra-
tions above the 95th percentile compared
with non-Hispanic blacks. These differences
likely result from increased use of sunscreens
by people with lighter skin pigmentation.
According to the authors, the NHANES
2003–2004 data can be used to establish a
nationally representative baseline assessment
of exposure. Moreover, the data could aid
risk assessments for BP-3 exposure if future
toxicologic or epidemiologic studies suggest
the need for such research, and may encourage
further research to determine the potential
public health impact of exposure at the levels
reported. –John Tibbetts
Environews | Science Selections
In an NHANES sample, 
women and light-skinned
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New Window into Breast 
Cancer Risk
Assessing Lifetime Exposures to POPs
Persistent organic pollutants (POPs) such as polychlorinated
biphenyls (PCBs) are ubiquitous chemical compounds that persist in
the environment and bioaccumulate through the food web. Although
experiments have shown that POPs stimulate the proliferation of
human cancer cell lines, epidemiologic studies of POP-associated
cancer risk have yielded inconsistent results, possibly because of the
lack of tools for estimating lifetime exposures to these chemicals.
Now, however, researchers have developed a new physiologically
based pharmacokinetic (PBPK) modeling approach that can poten-
tially be used in epidemiologic studies to simulate lifetime toxico-
kinetics of POPs in women [EHP 116:886–892; Verner et al.].
Previous biological assessments have been limited to measuring
POP levels in blood or tissue samples collected around the time of
breast cancer diagnosis. However, such assessments may not reflect the
body burden during earlier, potentially critical exposure points in a
woman’s life such as the fetal, postnatal, and adolescent periods. 
In contrast, the new model integrates the relevant processes of
absorption, distribution, metabolism, and elimination to estimate life-
time blood and tissue exposure and levels during any hypothesized
time window of susceptibility in breast cancer development. The
model also predicts how various types of relevant lifetime physiologic
changes—such as body weight variation, pregnancy, excretion of
POPs through lactation, and aging—will influence the kinetics of a
compound in a woman throughout her life. The model enables the
estimation of interindividual differences in POP exposures through the
use of physiologic information obtained from questionnaires in epi-
demiologic studies.
The researchers found that lactation and weight change histories
had the greatest impact on the toxicokinetic profile throughout life.
According to the model, the longer and later in life lactation occurred,
the lower the woman’s blood POP concentration at age 55 (a surro-
gate time representing the typical age at breast cancer diagnosis).
Similarly, variations in body weight throughout life had a greater
impact than average body weight on blood POP concentrations, possi-
bly because weight loss is accompanied by unloading of POPs into the
blood via lost adipose tissue. This means that quantitative information
on both lactation and body weight histories is critical when evaluating
past POP exposures.
If, as some researchers hypothesize, breast cancer is related to
POP exposures at specific time windows of susceptibility during a
woman’s lifetime, lactation and body weight histories must be con-
sidered in studies of POP exposures and breast cancer risk.
Depending on when such physiologic events occur, women having
similar POP concentrations at the age of diagnosis may have had
completely different internal levels at a time that may be critical to
the formation of breast cancer. The proposed PBPK modeling
approach therefore could be used in environmental epidemiology
research to circumvent limitations inherent in relying on late-life
sampling for past exposure assessments. –M. Nathaniel Mead
Mischief Makers
Secondhand Smoke, Lead Linked to 
Conduct Disorder
A study of 3,081 U.S. children now confirms the results of smaller
studies associating exposure to secondhand tobacco smoke and lead
with conduct disorder (CD), a persistent disruptive behavior pattern
that includes aggression, lying, stealing, and destruction of property
[EHP 116:956–962; Braun et al.]. According to the study authors,
postnatal lead exposure and both pre- and postnatal exposure to
secondhand smoke can significantly increase the risk of CD in chil-
dren. Children with CD face a higher risk of anxiety disorders and
substance abuse.
Using data from the National Health and Nutrition Exam-
ination Survey (NHANES) 2001–2004, the researchers obtained a
nationally representative sample of children aged 8–15 years (earlier
studies by other researchers relied on smaller regional samples col-
lected from clinic visits). Caregiver responses to a questionnaire
known as the Diagnostic Interview Schedule for Children deter-
mined whether children met CD diagnositic criteria established by
the Diagnostic and Statistical Manual of Mental Disorders IV.
Prenatal exposure to secondhand smoke was estimated based on
caregiver responses to questions regarding smoking habits during
pregnancy; postnatal exposure was measured using blood serum
concentrations of cotinine, a nicotine metabolite. Lead exposure
was determined by measuring blood lead concentrations. 
The research team identified CD in 2.1% of the subjects, cor-
roborating earlier prevalence estimates. The team determined that
children exposed prenatally to secondhand smoke were 3-fold more
likely to meet CD diagnostic criteria than those not exposed.
Youngsters exposed postnatally to the highest levels of secondhand
smoke were 9.15 times more likely to exhibit CD symptoms than
those exposed to the lowest levels. 
The research team also examined the association between behav-
ior and lead exposure, the results of which support those of previous
studies suggesting that elevated blood lead also is a risk factor for
CD. Children with blood lead levels higher than 1.5 µg/dL were
8.64 times more likely to have met CD diagnostic criteria in the
past year than children with levels lower than 0.7 µg/dL.
Limitations to the study include inability to infer causal rela-
tionships because of the cross-sectional nature of the data. In addi-
tion, the reported prevalence of CD could be underestimated
because caregivers completing the DISC module may not recog-
nize disruptive behaviors in their children. Nevertheless, the
authors suggest that millions of children are currently being
exposed to levels of secondhand smoke and lead that could
increase the risk for persistent, disruptive, and even violent behav-
ior, despite reductions in recent years in children’s exposure to
these toxicants. –Cynthia Washam
Science Selections
Recurrent disruptive
behavior may be
linked to lead or 
secondhand smoke
exposure